Screener
NewAmsterdam Pharma Company NAMS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's asset turnover?
- NewAmsterdam Pharma Company (NAMS) reported asset turnover of 0× in Q2 2026.
- How has NewAmsterdam Pharma Company's asset turnover changed year-over-year?
- NewAmsterdam Pharma Company's asset turnover decreased by 90.7% year-over-year, from 0.1× to 0×.
- What is the long-term trend for NewAmsterdam Pharma Company's asset turnover?
- Over 2 years (2023 to 2025), NewAmsterdam Pharma Company's asset turnover has grown at a -10.2% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about NewAmsterdam Pharma Company's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude